Shares of ValiRx Plc (LON:VAL) passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.00 and traded as high as $0.20. ValiRx shares last traded at $0.18, with a volume of 49,539,419 shares traded.
The company has a debt-to-equity ratio of 10.35, a current ratio of 0.84 and a quick ratio of 0.77. The company has a fifty day moving average price of GBX 0.29. The stock has a market capitalization of $1.36 million and a PE ratio of -0.20.
ValiRx Company Profile (LON:VAL)
ValiRx plc, a biotechnology oncology focused company, engages in developing novel treatments for cancer and associated biomarkers in the United Kingdom. Its proprietary GeneICE technology enables the selective silencing of specific genes by targeted histone deacetylation leading to chromatin condensation.
Further Reading: What are different types of coverage ratios?
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.